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ABSTRACT
The chicken lysozyme gene is constitutively active in macrophages and under the control of
steroid hormones in the oviduct.To investigate which DNA elements are involved in the control
of its expression in macrophages we performed transient DNA transfer experiments with two
different types of plasmids: 5'-deletion mutants of the upstream region of the chicken
lysozyme gene and different fragments from this area in front of the thymidine kinase
promoter (herpes simplex virus), each placed in front of the CAT (chloramphenicol acetyl
transferase) coding sequence. Two enhancers (E-2.7kb and E-0.2kb) were characterized.
They are active in macrophages, but not in chicken fibroblasts. Furthermore a negative
element (N-2.4kb) was identified, which is active in fibroblasts and promyelocytes, but not
in mature macrophages. The combined action of all three elements contributes to the observed
lysozyme gene activities: no activity in fibroblasts, moderate activity in promyelocytes and
high activity in mature macrophages.
INTRODUCTION
Lysozyme, a specific differentiation marker for the myeloid lineage of hematopoietic
differentiation in mammals (1), is also expressed in chicken macrophages (2). The inactive
chicken lysozyme gene is activated during macrophage differentiation. Constitutive
expression increases from myeloblasts to mature macrophages (2). In addition to this
constitutive expression the chicken lysozyme gene is inducible by steroid hormones in the
tubular gland cells of the oviduct (3). This steroid induction is mediated by DNA sequences in
the immediate vicinity of the promoter (4,5). Lysozyme mRNA in both chicken macrophages
and oviduct cells derives from the same lysozyme gene and initiates at identical start sites
(2). Here we wanted to identify the control regions responsible for the macrophage specific
expression.
Using the DNA transfer technique tissue specific enhancer elements have been identified for
several genes, including those for immunoglobulin (6,7,8), chymotrypsin, amylase and
insulin (9), albumin (10), muscle actin (11), o-fetoprotein (12,13), fibroin (14) and
elastase (15). In the case of the chicken lysozyme gene a macrophage specific enhancer
sequence at -6.1kb 5' of the transcriptional start site has been identified (16). Since this
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enhancer is active in a myeloid cell line, which synthesizes about one third of the lysozyme
amount found in mature macrophages (16), we wanted to know whether additional regulatory
elements contribute to the lysozyme gene activity found in mature macrophages. Here we
describe two enhancer elements and one negative element, all of which show a tissue
specificity. Activity of all three elements in the myeloid cell line leads to a moderate activity
of a transfected reporter gene; in mature macrophages a high expression is observed, since
the negative element is inactive while the enhancer sequences are active.
MATERIALS AND METHODS
Plasmids
Plasmids were constructed by standard techniques (17). Sense or antisense orientations are
indicated by "s" or "a", respectively. Deletion end points and restriction fusion sites were
veryfied by sequencing (18) except for deletion end points further upstream than -380 bp.
The DNA sequence of the enhancer fragment -2.71kb/-2.54kb and the negatively acting
fragment -2.54kb/-2.25kb was determined for both strands. Before transfection all DNA
samples were purified by two centrifugations in CsCI gradients and analyzed on agarose gels to
assess the purity and quality of supercoiled DNA. All lysozyme fragments were isolated from
subclones of x lys3O (19).
5'Deletion Series (plysCATA-n). 5'deletion mutants (4) were cloned with their HindlIl sites
and their filled in EcoRI site into the HindlIl and filled in Bglll sites of vector ptkCAT3 (20),
thereby removing the tk (thymidine kinase) fragment.
plys-4.60/-2.71 s tkCAT: plys-4.60/-2.71 a tkCAT: plys-2.71/-1 .42s tkCAT:
plys-2.71/-1.42a tkCAT. The two HindlIl lysozyme gene fragments (-4.60kb/-2.71kb and
-2.71kb/-1.42kb) were ligated into the unique HindlIl site of pBL-CAT2 at position -109 of
the tk-promoter. pBL-CAT2 is a vector containing the CAT gene (chloramphenicol acetyl
transferase) driven by the tk promoter (B.Luckow and G.Schutz, unpublished). This vector
contains convenient polylinker sequences 5' and 3' of the tk-CAT fusion gene.
plys-2.71/-2.25a tkCAL pBL-CAT2 was linearized with Xbal, filled in, recut with Hindlil
and ligated with the 465bp long HindlIl/Scal lysozyme fragment (-2.71kb1-2.25kb).
plys-2.54/-2.25s tkCAT: plys-2.54/-2.25a tkCAT. The 300bp lysozyme gene fragment
Bglll/Scal (-2.54kb/-2.25kb) was cloned into the Bglll/Smal sites of plC1 9H (21). For
integration in both orientations in front of the tk-promoter, the fragment was removed from
the plC vector either by HindlIl and BamHl or by HindlIl and Bglll digestion and ligated into
the HindlIl plus BamHl opened vector pBL-CAT2.
plys-2.54/-2.34s tkCAT. The 205bp Bglll/Pvull lysozyme fragment was cloned into the
BgIllVSmal sites of plC19H, removed again by digestion with BamHl and HindlIl and inserted
into the HindlIl plus BamHl opened vector pBL-CAT2.
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plys-2.71/-2.54s tkCAT. The 165bp Hindlil/Bglll lysozyme fragment was ligated into the
Hindlil and BamHI digested vector pBL-CAT2 in sense orientation.
plys-2.71/-2.54a tkCAT. After digestion of pBL-CAT2 with BamHl plus Bglll the tk-
promoter was replaced by the Bglll fragment from plys-2.71/-1.42a tkCAT containing
lysozyme gene upstream sequences -2.54kb/-2.71 kb in addition to the tk-promoter
(-1O9bp to +51bp).
plys-2.69/-2.54s tkCAT: plys-2.63/-2.54s tkCAT. Lysozyme sequences -2.69/-2.54
(148bp Rsal/Bglll fragment) and -2.63/-2.54 (87bp SspI/BgIll fragment) were cloned
into the HindlIl and filled in Xbal sites of vector pBL-CAT2.
ptkCATlys-2.71/-2.54a. Integration of the 165bp Hindlil/Bglll (-2.71 kb/-2.54kb)
lysozyme fragment behind the tkCAT sequences within the vector pBL-CAT2 was achieved by
subcloning this fragment into pIC20R (21), subsequent isolation as a Sstl fragment and
integration into the Smal site of pBL-CAT2.
plys-2.71/-2.63s tkCAT. The 78bp Hindlil/Sspl lysozyme fragment was ligated into the Xbal
(filled in) and HindlIl sites of vector pBL-CAT2.
plys-1.42/-254s tkCAT. The -1.42kb/-254bp lysozyme fragment was isolated by partial
Rsal digestion followed by HindIll digestion and cloned into the HindIll and Hindll sites of the
vector pUC19 (22). This fragment was again removed by digestion with HindIll and BamHI
and inserted into the vector pBL-CAT2 using the Identical cloning sites.
plys-208/-66a tkCAT. This plasmid, a gift of R. Miksicek and G. SchOtz, contains lysozyme
sequences from -208bp to -66bp in antisense orientation in front of position -109bp of the
tk promoter.
pE-2.7kbA-208CAT. The 165bp Hindlll/Bglll fragment was isolated from
plys-2.71/-2.25s tkCAT and integrated into the plasmid plysCATA-208 by replacing the
polylinker from the HindlIl to the BamHl restriction sites.
pSVtkCAT(Constructed by J.Altschmied). The 72 bp repeats of the SV40 enhancer were
excised as a BamHl fragment from ptkCAT14C (gift of R.Miksicek and G.SchOtz) and inserted
into the unique BamHl site of pBL-CAT2.
pGEM1tkCAT. This in vitro transcription vector was generated by inserting an EcoRI
fragment of pBL-CAT2 (fragment -80bp to +323bp of the tk-CAT fusion gene) in antisense
orientation into the EcoRI site of pGEM1 (Promega Biotec).
Call Culture
HDI1 {- HBC1 = LSCC-HD(MC/MA1)) cells (23) and CEF38 cells (24) were grown in
standard growth medium (Dulbecco's modified Eagle's medium (DMEM, Biochrom)
supplemented with 8% fetal calf serum (Blochrom), 2% chicken serum (Gibco), and 10 mM
Hepes, pH 7.4. The medium contained 100 units/ml penicillin and 100 jg/ml streptomycin.
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For continuous growth, the cells were diluted between three and ten fold every three days.
Bone marrow primary macrophages were prepared from 7-12 days old White Leghorn chicks
as described by Graf (25). The bone marrow cells were seeded on 14.5 cm dishes (Falcon) in
growth medium (see above). After one day the fibroblast-depleted supernatant was
distributed on fresh dishes and incubated for 6 days. The supernatant was removed and the
adherent macrophages were kept in culture for further 7 days, trypsinized and seeded out on
6 cm dishes for DNA transfections (2 d before transfer).
DNA Transfection
All transfections were carried out in triplicate experiments and repeated at least twice. One
day prior to transfection, cells of cell lines were seeded on 6 cm dishes (Falcon) at
jxl06cells/plate (HD11) or 1x105cells/plate (CEF38). Medium was changed 4 hrs before
adding the DNA to the cells. For transient expression 1 pmol of superhelical DNA was
transfected per dish by the calcium phosphate method (26). After 20 hrs at 370C the
precipitates were removed, the cells washed, and in the case of HD11 cells additionally
shocked for 3 min with 1 ml 15% glycerol in 1xHBS. Cells were fed with fresh medium 24
hrs before harvesting. Calcium phosphate transfections of primary macrophages were
performed ten days after isolation on 6 cm dishes according to Wigler et al. (27). For
transfection 1.5pmol plasmid DNA was filled up with high molecular weight calf thymus DNA
to a total amount of 15 iLg per sample. After 20 hrs of exposure to DNA, cells were shocked
for 3 min with Iml 15% glycerol in 1x HBS and fed with fresh medium 24 hrs before
harvesting.
CATAsa
CAT assays were performed according to Gorman et al. (28) with modifications: Cells were
disrupted by 3 cycles of freezing and thawing. After centrifugation the protein concentration
of the supernatant was measured and identical protein amounts per sample were used for the
enzymatic reaction.
Preparation of Total RNA
Total cellular RNA was extracted by the guanidinium isothiocyanate procedure as described
(29,17). The RNA was prepared from 107cells 48 hrs after transfection with a chimeric
CAT construct. Cells transfected in parallel were harvested at the same time and used for CAT
assays as described above.
Preparation of Complementary RNA Probes
The template plasmid pGemltkCAT was linearized with BamHl, phenol extracted and ethanol
precipitated. Transcription was carried out for 1 hour at 400C under the conditions described
by Melton et al. (30), using 1 unit/jl of T7 phage RNA-polymerase. 25 FM c-32P-UTP
(400 CVmmole) was used for labelling the probe. The transcription mix was treated with
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RNase-free DNasel (Boehringer) for 10 minutes at 370C, phenol extracted and ethanol
precipitated. The RNA pellet was redissolved in 80% Formamide, 1 xTBE, loaded on a 5%
polyacrylamide/8M urea gel and the full length transcript was isolated by electroelution.
RNaseMping
Hybridization and RNase mapping were performed essentially as described by Melton et al.
(30). 50 9g of total cellular RNA were hybridized overnight with 1-5x105 cpm of RNA
probe at 420C. RNase digestion took place in the presence of 50 units/ml RNase Ti
(Boehringer) and 3 mg/ml RNase A (Boehringer) at 370C.
RESULTS
Negative and Positive Elements Control Lysozyme Gene Expression in a Chicken Macrophage
Cell Lina
To test the expression of transfected lysozyme gene recombinants we chose the macrophage
cell line HDI1. This is an established line of chicken macrophages transformed by the
myc-containing MC 29 virus (23,31). The activity of the lysozyme gene is about one third
of that detected in primary cultures of mature macrophages (2,16). Plasmids containing
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Figure 1. CAT expression of the IysCAT 5'deletion series in the macrophage cell line HD1 1.
Transient expression from each of the plysCATA-n plasmids was determined in triplicate
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Figure 2. Dissection of 4.6kb upstream sequences into four segments.
Four lysozyme upstream sequences were cloned in front of the tkCAT fusion gene and
transfected into HD11 cells. Schematic representation of lysozyme constructs in sense (s) or
antisense (a) orientation are shown. Mean values of CAT activities with their standard
deviations are expressed relative to the activity measured with pBL-CAT2 (tkCAT).
transfected into HD11 cells, which were then analyzed for CAT activity (figure 1). The
amount of CAT activity determined is markedly dependent on the deletion mutant used: mutant
-208bp shows the highest expression, whereas further deletion of 10bp (mutant -198bp)
results in only background activity. Maintaining 230bp or more upstream of the start site
leads to a suppression of the CAT activity. This highly reproducible patterns of increase and
subsequent decrease in CAT expression with the inclusion of progressively more 5' sequences
indicated that lysozyme gene activity may be controlled by both positively and negatively
acting elements. Since it is difficult to analyze such an organization with deletion mutants, we
divided 4.6kb of lysozyme upstream sequences into 4 fragments. These fragments were
cloned in front of the herpes simplex thymidine kinase promoter (tk) of the vector
pBL-CAT2 (gift of B. Luckow and G. SchDtz). The CAT expression from these recombinants in
HD11 cells (figure 2) showed some enhancer activity from lysozyme sequences
-2.71kb/-1.42kb and -208bp/-66bp, even in the anti-sense orientation. A negative effect
was observed with lysozyme fragment -1.42kb/-253bp. Since we wanted to focus first on
the enhancer sequences, the fragment -1.42kb/-253bp was not further analyzed.
Two Enhancer Elements Can be Identified which are Multiplicative in their Effects
Based on the results shown in figure 2 we sub-divided the long -2.71kb/-1.42kb fragment
into small segments. Analysis of the effects of these sequences on CAT expression revealed
enhancer activity of a fragment from -2.71kb to -2.54kb (figure 3B). Hence at least two
enhancer elements, each of about 150bp, were found to be active in HDI1 cells. These two
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E-2.7kb fragments act on correctly
CAT assay and RNA start site mapping experiments were performed on HD1 1 cells after
transfection with lys-tkCAT constructs containing the E-0.2kb or the E-2.7kb enhancer
sequences. A Diagram of lysozyme upstream sequences cloned in front of tkCAT with their CAT
activities shown. B RNA transcript mapping and CAT activities of plys-208/-66a tkCAT
(E-0.2a) and pBL-CAT2 (tkCAT). In addition to the +1 start the size of the labelled RNA
probe (Probe) and Hinfl digested end labelled pBR322 (Marker) are shown. A thin layer
chromatogram exhibits the amounts of 14C-chloramphenicol (lower spot) and of the
acetylated forms (upper spots). C RNA transcript mapping and CAT activities of E-2.7s,
E-2.7a and bE-2.7. D Diagram depicting the different constructs used and the length of the
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Figure 4. Deiineation of the E-2.7kb enhancer.
CAT activities of the different Iys-tkCAT constructs after transfection into HD1 1 celis are
shown reiative to the tkCAT value (for details see figure 2).
cloned in inverse orientation in front of the tk promoter, stiii induce the CAT activity
(figure 3B,C). Also when cioned behind the CAT gene the enhancer element E-2.7kb exerts its
enhancing activity (ptk-CAT-lys-2.71 /-2.54s, figure 30).
Since CAT assays do not reveal whether the correct start sites for transcription are used, RNA
transcripts were analyzed directly using the RNase start site mapping procedure (30,32).
These assays showed only one start site, which is identical with the regular tk-start site
(+1; figure 3B,C). The amounts of the +1 RNA transcribed from the different constructs
follows exactly the pattern derived from the CAT assays. Therefore, we conclude that the two
enhancer elements act on the correct start site of transcription.
To delineate more precisely the borders of the enhancer sequences, we divided the sequence
from -2.71kb to -2.54kb into overlapping fragments. After cloning in pBL-CAT2 and
transfection into HD11 macrophages we determined CAT activities of cellular extracts (figure
4). Since Iys-2.69/-2.54 shows full enhancer activity, while Iys-2.71/-2.63 retains
some activity, and Iys -2.63/-2.54 is inactive, the 5'border of the enhancer can be
positioned between -2.69kb and -2.63kb and the 3'border between -2.63kb and -2.54kb.
The 5'border of the E-0.2kb enhancer is defined by the two deletion mutants -208bp and
-198bp (figure 1). The 3'end of the enhancer fragment (-66bp) can not be shortened
without loss of enhancing activity (not shown). Since we determined the enhancer activity of
the individual E-2.7kb and E-0.2kb fragments, we wanted to measure their combined effects
on the Iysozyme promoter. The basal activity of the Iysozyme promoter is determined from
the deietion mutant -198bp. Addition of 10Obp restores the E-0.2kb enhancer activity which












Figure 5. Multiplicative action of the combined enhancer sequences E-0.2kb and E-2.7kb.
Plasmids plysCATA-208 and E-2.7ba-208 contain the E-0.2kb and the E-0.2kb plus the
E-2.7kb enhacer, respectively. CAT activities of these plasmids after transfection into HD11
cells are expressed relative to the activity found with the enhancerless construct
plysCATA-1 98.
leads to about 200-fold induction proving the multiplicative effects of the combined
enhancers.
A Negative Element is Located Immediately Downstream of the E-2.7kb Enhancer
In our attempt to characterize the E-2.7kb enhancer, we found different degrees of enhancing
activity depending on the presence of sequences downstream of the E-2.7kb enhancer (figure
3A). To analyze this phenomenon, we cloned three overlapping fragments into pBL-CAT 2: lys
-2.71/-2.25, lys -2.71/-2.54 and lys -2.54/-2.25. After transient expression in HD1 1
cells we determined a high CAT activity for the E-2.7kb enhancer, a reduced enhancing
activity after testing a longer fragment containing an additional sequence (-2.54/-2.25) and
even an inhibition of the tk promoter activity by the sequence -2.54/-2.25 alone,
independent of its orientation (figure 6A). Further deletion into this fragment weakens the
negative effect.
This evidence was again confirmed using the RNase start site mapping procedure, which
revealed a 2-3 fold lower enhancement by lys-2.71/-2.25 than by lys -2.71/-2.54
(figure 6). The effect of the negative element on the tk promoter without enhancer sequence
could not be measured by the RNase mapping technique since the expression of this construct
is reduced below the detection limits of this assay.
These data show that the negative element (N-2.4kb), independent of its orientation, can
reduce tk promoter activity both in the presence or absence of the E-2.7kb enhancer element.
We hybridized N-2.4kb DNA to a "Southern" blot of chicken genomic DNA and found that this


















Figure 6. The lysozyme upstream sequence -2.54kb to -2.25kb (N-2.4kb) decreases
transcription.
Different lysozyme sequences cloned in front of the tkCAT fusion gene were transfected into
HDI I cells and assayed for their CAT activitly and RNA start site. A Schematic representation
of lysozyme constructs and their CAT activities In sense (s) or antisense (a) orientation. B
RNA start site mapping experiment and C thin layer chromatogram of the CAT assay as shown
in figure 3.
Both Positive and the Negative Elements Act in a Tissue Specific Manner
Our aim was to analyze the macrophage specific expression of the chicken lysozyme gene.
Therefore, we wanted to test the activity of the two enhancer elements and of the negative
element In different cell types. In addition to the chicken myeloid cell line HDI1 (not fully
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Figure 7. Cell specificity of the enhancer elements and of the negative element.
The fibroblast cell line CEF38, the promacrophage line HD1 1 and primary mature
macrophages were transfected with plys-2.54/-2.25s tkCAT (N-2.4), plys-208/-66a
tkCAT (E-0.2), plys-2.71/-2.54s tkCAT (E-2.7) and as control pBL-CAT2 (tkCAT) and
pSVtkCAT (SV40) CAT values are expressed relative to the activity measured from
pBL-CAT2. The diagram and table at the bottom of the figure depict the positions of the three
elements and their effects in the different cell types tested. HRE I and 11 are the two hormone
responsive elements (4,5).
fibroblast cell line CEF 38. Both enhancer elements are active In the macrophage cell line,
somewhat more active in the primary mature macrophages, but are inactive in the fibroblast
line (figure 7). These elements, therefore, seem to contribute tissue specifically to the
lysozyme expression in the macrophage cells. The negative element lys-2.54/-2.25
represses transcription from the tk-promoter in fibroblast and the myeloid cell line, but is
neutral in the primary mature macrophages (figure 7).
Sequence Comparisons
The two enhancer sequences E-2.7kb and E-0.2kb were compared with each other and with
other known enhancer sequences. Comparison with each other revealed a sequence element,








































Figure 8. Sequence analysis of the three lysozyme regulatory elements.
A The E-2.7kb enhancer fragment contains sequences homologous to the SV40 p (p) and core
(core) motifs (33,36), to the Ig octamer (octa) sequence (8,37) and to the lysozyme
enhancer E-0.2kb (lys). The filled or open bars indicate the length of the homologous
sequence, shaded areas indicate non-matching nucleotides. B The E-0.2kb enhancer element
shows homologies to the SV40 core (core) and Sph motif (Sph) (33,36), to the nuclear
factor 1 (NFI) binding site (38) and two sequences homologous to each other and to the
lysozyme enhancer E-2.7kb (lys). C All "core" and "lys" homologies are compiled and
compared to the cytomegalovirus enhancer (CMV) (37). D The sequence of the N-2.4kb
element.
homology to the SV40 enhancer core sequence (33,34) as well as to the CMV enhancer (35).
This homology is pointed out in figure 8C. Further comparison of E-2.7kb and E-0.2kb with











homologous regions in E-0.2kb and one in E-2.7kb. One homology to the Sph element of the
SV40 enhancer domain A (36) was found in E-0.2kb and one homology to the P motif of the
SV40 enhancer domain A was detected in E-2.7kb. One sequence element homologous to the
octamer motive (Ig gene; 8,37) and one homologous to the NFl binding site (38) were
identified in E-2.7kb and E-0.2kb, respectively (figure 8A and B). In addition to these
homologies the enhancer E-0.2kb contains binding sites for both the glucocorticoid receptor
and the progesterone receptors (4,5).
DISCUSSION
By analyzing upstream sequences of the chicken lysozyme gene with transient DNA transfer
experiments in chicken macrophage cells we have identified three distinct regulatory
sequences. Two elements act as macrophage specific enhancer elements and one is a negative
element, which is inactive in mature macrophages.
Other tissue specific genes have also been found to be regulated by tissue specific enhancer
sequences (for review see (39)). In several of these cases sequence homologies or protein
binding experiments have shown that some of the components which build up a tissue specific
enhancer can also be found in enhancer elements of different specificity or in combination
with promoter or replication function. E.g. the octamer motif within the lymphocyte specific
immunoglobulin enhancer (6,7) is also found upstream of many other genes (40). Nuclear
factor 1, a protein required for adenovirus replication (41) has been shown to be an
ubiquitous factor, which binds to several enhancer sequences (for review see (42)) and to
the CCAAT promoter element (43); it also binds to a 579 bp lysozyme fragment, which acts
as a macrophage specific enhancer element (16). The macrophage specific enhancer E-0.2kb
also contains a significant homology to the NF1 binding consensus sequence, whereas the
enhancer sequence E-2.7kb does not. Several homologies to the SV40 enhancer can be seen in
both these enhancer sequences, as well as in the IgH enhancer (6,7,36), CMV enhancer (35),
adenovirus 2 El a enhancer (44) and the c-fos enhancer (45).
Multiple homologies both between lysozyme enhancer sequences (E-2.7kb and E-0.2kb) and
with other enhancer elements suggest a complex modular structure. This is emphasized by the
fact that the footprint region of the progesterone and glucocorticoid receptors (4,5) within
the E-0.2kb element can not be deleted without destroying enhancer activity since 5'deletion
mutant -164bp loses enhancer activity as well as steroid regulation in oviduct cells (4). The
observed enhancer activity in macrophages is not due to a steroid induction, since the use of
antihormones did not influence enhancer activity (not shown). This may indicate that steroid
receptors and enhancer binding factors can recognize similar DNA sequences. Such a
possibility has been discussed recently, since the DNA binding domains of steroid receptors,
4175
Nucleic Acids Research
the thyroid receptor and the viral erbA product are quite homologous (for review see: (46)).
In the chicken ovalbumin gene sequences required for steroid regulation have also been found
to overlap with another upstream regulatory region, which is in this case a 'blocker'
sequence (47).
For the chicken lysozyme gene we identified a negative element in the immediate vicinity of an
enhancer sequence. This negative element at -2.4kb upstream of the start site suppresses
enhancer function of the E-2.7kb enhancer in an incompletely differentiated macrophage
line, but is inactive and therefore allows complete enhancer activity in mature macrophages.
Cell specific negative elements have also been found to regulate expression of other genes: rat
growth hormone gene (48), rat &-fetoprotein gene (12), rat insulin 1 gene (49) and the IgH
gene (50), and in some cases appear to be closely associated with an enhancer sequence.
In several cases, DNase I hypersensitive sites of the chromatin reflect positions for
regulatory sequences. All three identified lysozyme regulatory sequences, E-2.7kb, N-2.4kb
and E-0.2kb are located in regions of previously determined hypersensitive sites (HS) (51).
Appearance and disappearance of these sites follows exactly the observed activities of the
three elements: HS-2.7 and HS-0.lkb are present in macrophages, but are absent in
fibroblasts, whereas HS-2.4kb is absent in mature macrophages, the only cell type in which
we find the negative element N-2.4kb to be neutral. Based on this correlation, and on the
tissue specific effect of the negative element, we conclude that N-2.4kb as well as E-2.7kb
and E-0.2kb probably interact with cellular factors.
The additive effect of all the regulatory elements described here, together with the enhancer
at -6.1kb (16) and possibly together with as yet unidentified sequence elements, probably
activate the chicken lysozyme gene during the differentiation of macrophages. A similar
regulation by a complex array of positive and negative regulatory regions has been found for
the rat and mouse oc-fetoprotein genes (12,13). Since the precise arrangement of these
elements does not appear to be of absolute importance to their function, the multitude of
different regulatory regions might have served during evolution to modulate both the
magnitude and the tissue specificity of gene activity.
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